In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback